05.05.2013 Views

Health Systems in Transition - Hungary - World Health Organization ...

Health Systems in Transition - Hungary - World Health Organization ...

Health Systems in Transition - Hungary - World Health Organization ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Health</strong> systems <strong>in</strong> transition <strong>Hungary</strong> 69<br />

Fig. 3.5<br />

Total expenditure on health accord<strong>in</strong>g to source and adm<strong>in</strong>ister<strong>in</strong>g agent, 2009<br />

Source: Author’s adaptation based on WHO NHA.<br />

32.5% HIF Contributions<br />

10.9% Government (central and local budgets)<br />

24.0% Hypothecated tax and other HIF transfers<br />

23.7% Out-of-pocket payments<br />

2.7% VHI (premiums and MSA)<br />

2.2% Non-profit <strong>in</strong>stitutions<br />

1.7% Corporations<br />

2.3% Other SHI contributions (e.g. self-employed)<br />

Whereas recurrent expenditure is f<strong>in</strong>anced by the HIF, nearly all capital<br />

<strong>in</strong>vestment related to outpatient and <strong>in</strong>patient care is f<strong>in</strong>anced by the central and<br />

local governments. Nonetheless, the central government still pays for recurrent<br />

expenditure related to certa<strong>in</strong> services (for example, high-cost high-technology<br />

treatments and public health) and covers co-payments for residents with very<br />

low <strong>in</strong>comes. S<strong>in</strong>ce the mid-1990s, governments <strong>in</strong> <strong>Hungary</strong> have used cuts <strong>in</strong><br />

the SHI contribution rate as one of their ma<strong>in</strong> tools for boost<strong>in</strong>g employment,<br />

but have failed to compensate the HIF adequately for the result<strong>in</strong>g shortfall<br />

<strong>in</strong> revenue, lead<strong>in</strong>g to a prolonged f<strong>in</strong>ancial imbalance (see section 3.3.3).<br />

Private health <strong>in</strong>surance plays a fairly limited role <strong>in</strong> health care f<strong>in</strong>anc<strong>in</strong>g,<br />

with a share of 2.7% of the total health expenditure <strong>in</strong> 2009 (Table 3.1). Most<br />

of the expenditure under the private health <strong>in</strong>surance head<strong>in</strong>g is actually not<br />

<strong>in</strong>surance, but <strong>in</strong>dividual medical sav<strong>in</strong>gs accounts (MSAs) without any pool<strong>in</strong>g<br />

across <strong>in</strong>dividuals beyond the family. The MSA scheme has benefited from<br />

tax subsidies, but <strong>in</strong> recent years these subsidies have been reduced and the<br />

scope of services that the MSA scheme can cover was also restricted. Overall,<br />

OOP expenditure cont<strong>in</strong>ues to be the dom<strong>in</strong>ant form of private expenditure <strong>in</strong><br />

<strong>Hungary</strong> (see section 3.4).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!